For almost 3 decades, cold storage (CS) has been the standard method used to preserve liver grafts prior to transplantation. However, marginal grafts are susceptible to cold ischemia, making CS a suboptimal preservation modality for these organs. The transplant community has recently become increasingly interested in the application of normothermic machine perfusion (NMP), an innovative preservation technique. NMP maintains the liver graft's metabolism by continuously supplying oxygen and nutrients at physiologic temperature. Studies indicate that NMP can restore energy content, hepatobiliary function, and microcirculation, thus improving liver quality prior to transplantation. More importantly, NMP holds the potential to increase the duration of organ preservation, which can minimize logistical limitations of CS, recondition injured organs, and manipulate the graft to improve transplant outcomes. As of today, the longest recorded maintenance of active liver metabolism of human organs outside of the body is 24 hours (1) and 72 hours in a porcine model.
increase the duration of organ preservation, which can minimize logistical limitations of CS, recondition injured organs, and manipulate the graft to improve transplant outcomes. As of today, the longest recorded maintenance of active liver metabolism of human organs outside of the body is 24 hours (1) and 72 hours in a porcine model. (2) Herein, we report a case describing the metabolic activity of a discarded human liver during 86 hours of ex situ NMP.
Materials and Methods
A liver was procured from a 53-year-old donor after circulatory death (Maastricht Category III). Two minutes after extubation, the mean arterial pressure was lower than 60 mm Hg, and arterial oxygen saturation was lower than 80%. This was the beginning of warm ischemia time (WIT). Six minutes after that, the donor had cardiac arrest and was declared dead. Incision started after 5 minutes of no-touch after death declaration. Cold flushing started at 2 minutes after incision. The time from the beginning of WIT to cold flushing was 13 minutes. After being declined for transplantation due to severe sclerosis of common hepatic artery (HA) and iliac vessels, the liver was offered to our NMP research team. Cold ischemia time before NMP was 4 hours and 15 minutes in histidine tryptophan ketoglutarate solution. Using our NMP system that has been previously described, (3) the liver was placed in a container on a soft biocompatible resting mattress to prevent injury of the tissue. The HA and the portal vein (PV) were cannulated, and perfusion was initiated. The perfusate consisted of 4 units of ABO graft compatible fresh frozen plasma (FFP) and 2 units of packed red blood cells (PRBCs) obtained from our blood bank. The choice of this perfusate was based on our preclinical animal and discarded human liver research as well as the safety data reported by op den Dries et al. (4) The circuit was primed with heparin, insulin, calcium gluconate, antibiotics, and methylprednisolone. The infusion pressures were maintained within physiologic range Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; CS, cold storage; FFP, fresh frozen plasma; H & E, hematoxylin-eosin; HA, hepatic artery; NMP, normothermic machine perfusion; PRBC, packed red blood cell; PV, portal vein; WIT, warm ischemia time.
FIG. 1. (A)
The diagram of the liver perfusion system was presented, which consisted of an organ receptacle with a foam mattress at the bottom, a centrifugal pump, a roller pump, and an oxygenator/heat exchanger to maintain physiologic temperature and oxygen content in the perfusate. (B) The pH during NMP was maintained at 7.40-7.65. (C) Urea nitrogen in perfusate increased obviously in the first 12 hours and was above 100 mg/dL before each exchange and at 40-80 mg/dL after exchange. Liver had continuous (D) bile production and (E) lactate clearance during NMP. (F) AST and (G) ALT had a decrease after each perfusate exchange and a peak value at the 24th hour.
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(mean HA, 80-100 mm Hg; PV, 8-12 mm Hg) to support a total inflow of 1 mL/minute/g liver tissue (HA versus PV at 25% versus 75%). Outflow blood drained freely from the vena cava. Partial oxygen pressure at infusion was 200-300 mm Hg. Epoprostenol was infused at 9-60 lg/hour through the HA infusion line as a vasodilator. FFP (2 units, 500-550 mL) and PRBCs (1 unit, 300-350 mL) were added to the perfusate every 12 hours for the first 24 hours and every 22-24 hours thereafter, once the same amount of original perfusate was drained out of the circuit by changing the recirculating flow to a draining line through the venous sample port. This procedure was carried out to reload bile salts and to prevent buildup of potentially deleterious liver metabolites that could accumulate due to the nature of a close isolated system. Supplemental medications were replenished accordingly after perfusate exchange. Hematocrit was targeted to 15%-20%, and glucose was maintained above 60 mg/dL using additional dextrose (50%) supplements. Sodium bicarbonate and oxygen flow were adjusted to maintain pH at 7.45 6 0.15. Liver temperature was maintained at 368C-378C. Biopsies were taken on liver tissue before NMP, and after 12, 24, 48, 72, and 86 hours, and on bile duct (distal and left and right bile duct bifurcation) at the end of NMP.
Results
NMP was stable and no technical problems were observed during the entire 86-hour perfusion. Bile production was 8-10 mL/hour with an average bicarbonate concentration of 23 mmol/L in the first 54 hours and gradually decreased to 4 mL/hour with bicarbonate concentration of 14 mmol/L in the last 12 hours. The perfusate lactate was high at NMP initiation and after perfusate exchange due to the high lactate content of banked PRBCs. The liver quickly cleared lactate after NMP initiation and each perfusate exchange (Fig. 1) . The alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in the perfusate increased after NMP initiation and after each perfusate exchange (peak ALT, 3174 U/L; peak AST, 8678 U/ L). Urea nitrogen in perfusate was more than 100 mg/ dL before each perfusate exchange and decreased to 40-80 mg/dL after each exchange. Supplemental glucose infusion started from the 10th perfusion hour until the end of perfusion, resulting in a total of 38 g of glucose infused. Supplemental sodium bicarbonate was 15 mL during the entire NMP. The liver graft appeared soft and homogeneously perfused during NMP in more than 90% of the liver. Histological analysis showed normal parenchyma, preserved sinusoidal architecture, and viable hepatocytes. Only the most dependent rim of the liver parenchyma (2 3 5 cm) had severe contact injury and necrosis upon histology analysis. A cholangiogram indicated integrity of the bile duct at the end of NMP. Histology of the bile duct revealed intact peribiliary glands and mild cell proliferation (Fig. 2) . No bacterial growth was detected in the perfusate sampled at the beginning and end of NMP. Perfusion was discontinued after 86 hours as determined based on the availability of the research team to continuously monitor the organ.
Discussion
To the best of our knowledge, this case represents the longest reported maintenance of a human organ metabolism outside of the body. This is an important finding because longterm preservation could provide an opportunity for tissue regeneration (3) and organ reconditioning through pharmacologic, immunologic, and genetic interventions. (5) As a demonstration of intact metabolism, bile production and lactate clearance were preserved until the end of the 86 hours. The prompt lactate clearance (15 mmol/L) in the last 14 hours was an indication that hepatocellular function was well preserved, although the last time adding FFP and PRBCs induced a substantial increase of lactate content in perfusate. A slightly lower rate of bile production near the end of perfusion may have been due to the lack of enterohepatic circulation despite perfusate exchange, and the contact injury on liver parenchyma gradually occurred. Liver histology of the noncontact parenchyma showed completely healthy hepatocytes.
The ideal perfusion solution for NMP has yet to be identified and theoretically should mimic as closely as possible the environment present during physiologic conditions. Other researchers have successfully used PRBCs mixed with a colloid solution (gelofusine and Steen solution). The decision to use FFP as the colloid solution was based on the rationale that FFP is the most physiologic colloid solution available and has proven to be safe in preclinical bench studies. (4) Furthermore, we have used this combination successfully in more than 10 clinical liver transplants (ATC, Chicago 2017). In this study, we exchanged the perfusate every 12 hours for the first 24 hours (early perfusion phase) and every 20 hours thereafter (maintenance perfusion phase). Although no existing study has systematically explored the efficacy of perfusate exchange during NMP, we implemented an exchange schedule based on the theoretical understanding that toxic byproducts ought to be removed (urea, cytokines, etc.) as these levels significantly escalate.
One interesting finding was the necrotic contact damage identified at the bottom of the liver, despite positioning the liver on a foam mattress. This was unexpected and may explain the increase of transaminases in the perfusate after reaching a steady perfusion state. Future research on longterm organ preservation should address better modes of organ support to minimize tissue contact injury.
One limitation of our case worth noting was the absence of transplantation. Although, transplantation would have enabled us to identify associations between ex situ viability and transplant outcomes, it was not possible because we were using a discarded organ and did not have an approved US Food and Drug Administration trial to transplant such grafts. Nevertheless, successful transplants have been performed using ex situpreserved marginal grafts that presented levels of bile production and lactate clearance comparable to the ones observed in our study. Another limitation was the lack of molecular markers such as factor V, signaling protein, and tissue content of glycogen and adenosine triphosphate. They were not measured in this proof-of-concept report but are worth investigating in further studies. The third limitation was the lack of perfusate content correction after exchanging perfusate because the calculation on that procedure was not well developed yet.
In conclusion, this report indicates that active ex situ human liver metabolism and parenchymal architecture preservation can be achieved for up to 86 hours. Longterm preservation could revolutionize the field of organ and tissue transplantation by providing opportunities to enhance organ quality. To this end, proof-of-concept studies have already explored the potential of ex situ intervention to alter organ immunogenicity, enable gene delivery, and rescue severely injured organs. Further research ought to assess organ specific requirements for longterm perfusion (eg, type of perfusate, support system to minimize tissue injury, nutritional supplementation) and investigate organdirected intervention strategies that could be delivered during ex situ preservation.
